肺癌患者的免疫相关不良事件
Guilherme Sacchi de Camargo Correia1, Tanmayi Pai1, Shenduo Li1
1Division of Hematology and Medical Oncology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA.
Current oncology reports
|October 2, 2023
概括
免疫检查点抑制剂 (ICI) 对肺癌治疗至关重要,但可能导致与免疫相关的不良事件 (irAEs). 本综述详细介绍了肺癌患者的irAE频率,管理以及对治疗反应的影响.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 自2015年以来,免疫检查点抑制剂 (ICI) 已经彻底改变了肺癌治疗.
- 与免疫相关的不良事件 (irAEs) 是与ICI治疗相关的重大临床挑战.
研究的目的:
- 审查FDA批准的肺癌ICI临床试验 (2015-2023年).
- 为了确定常见的irAEs的频率,包括甲状腺功能低下症,肺炎,腹/结肠炎,皮疹和肝炎.
主要方法:
- 临床试验和社会指导方针的综合文献综述.
- 分析的重点是病理生理学,流行病学,诊断,分级和irAEs的管理.
- 探索iRAE与治疗反应之间的关系.
主要成果:
- 肺癌的ICI治疗与一系列的irAEs有关.
- 常见的irAEs包括内分泌,肺,胃肠道,皮肤和肝脏的毒性.
- 有效的管理策略对于患者的护理和治疗的延续至关重要.
结论:
- 了解和管理irAEs对于优化肺癌ICI治疗至关重要.
- 本综述为在不同临床环境中管理IRE的瘤学提供者提供了指导.
- 由于它们可能导致严重和危及生命的结果,管理IREs至关重要.
更多相关视频
相关概念视频
Other Pulmonary Disorders
865
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
865
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
474
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
474
Radiological Investigation II: MRI and Ventilation Perfusion Scan
143
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
143
Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
Pneumonia I: Introduction
262
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
262


